Global Duodenal Ulcer Treatment Market Size, Status and Forecast 2019-2025

Description

Duodenal ulcer is a sore occurring in the upper area of the small intestine, the duodenum.
Globally demand for duodenal ulcer treatment is expected to witness growth due to increasing prevalence of the disease.
In 2018, the global Duodenal Ulcer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Duodenal Ulcer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Duodenal Ulcer Treatment development in United States, Europe and China.

The key players covered in this study
GlaxoSmithKline
Pfizer
Abbott Laboratories
Merck
Nihon Pharmaceuticals
Novartis
Bristol Meyer Squibb
AstraZeneca
Takeda
Ei Sai

Market segment by Type, the product can be split into
Antibiotics
Proton Pump Inhibitors
Antacids
Potassium-Competitive Acid Blockers (P-CAB)
H2-Antagonist
Ulcer Protective Drugs
Surgery

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Duodenal Ulcer Treatment status, future forecast, growth opportunity, key market and key players.
To present the Duodenal Ulcer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Duodenal Ulcer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Duodenal Ulcer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibiotics
1.4.3 Proton Pump Inhibitors
1.4.4 Antacids
1.4.5 Potassium-Competitive Acid Blockers (P-CAB)
1.4.6 H2-Antagonist
1.4.7 Ulcer Protective Drugs
1.4.8 Surgery
1.5 Market by Application
1.5.1 Global Duodenal Ulcer Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Duodenal Ulcer Treatment Market Size
2.2 Duodenal Ulcer Treatment Growth Trends by Regions
2.2.1 Duodenal Ulcer Treatment Market Size by Regions (2014-2025)
2.2.2 Duodenal Ulcer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Duodenal Ulcer Treatment Market Size by Manufacturers
3.1.1 Global Duodenal Ulcer Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Duodenal Ulcer Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Duodenal Ulcer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Duodenal Ulcer Treatment Key Players Head office and Area Served
3.3 Key Players Duodenal Ulcer Treatment Product/Solution/Service
3.4 Date of Enter into Duodenal Ulcer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Duodenal Ulcer Treatment Market Size by Type (2014-2019)
4.2 Global Duodenal Ulcer Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Duodenal Ulcer Treatment Market Size (2014-2019)
5.2 Duodenal Ulcer Treatment Key Players in United States
5.3 United States Duodenal Ulcer Treatment Market Size by Type
5.4 United States Duodenal Ulcer Treatment Market Size by Application

6 Europe
6.1 Europe Duodenal Ulcer Treatment Market Size (2014-2019)
6.2 Duodenal Ulcer Treatment Key Players in Europe
6.3 Europe Duodenal Ulcer Treatment Market Size by Type
6.4 Europe Duodenal Ulcer Treatment Market Size by Application

7 China
7.1 China Duodenal Ulcer Treatment Market Size (2014-2019)
7.2 Duodenal Ulcer Treatment Key Players in China
7.3 China Duodenal Ulcer Treatment Market Size by Type
7.4 China Duodenal Ulcer Treatment Market Size by Application

8 Japan
8.1 Japan Duodenal Ulcer Treatment Market Size (2014-2019)
8.2 Duodenal Ulcer Treatment Key Players in Japan
8.3 Japan Duodenal Ulcer Treatment Market Size by Type
8.4 Japan Duodenal Ulcer Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Duodenal Ulcer Treatment Market Size (2014-2019)
9.2 Duodenal Ulcer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Duodenal Ulcer Treatment Market Size by Type
9.4 Southeast Asia Duodenal Ulcer Treatment Market Size by Application

10 India
10.1 India Duodenal Ulcer Treatment Market Size (2014-2019)
10.2 Duodenal Ulcer Treatment Key Players in India
10.3 India Duodenal Ulcer Treatment Market Size by Type
10.4 India Duodenal Ulcer Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Duodenal Ulcer Treatment Market Size (2014-2019)
11.2 Duodenal Ulcer Treatment Key Players in Central & South America
11.3 Central & South America Duodenal Ulcer Treatment Market Size by Type
11.4 Central & South America Duodenal Ulcer Treatment Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Duodenal Ulcer Treatment Introduction
12.1.4 GlaxoSmithKline Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Duodenal Ulcer Treatment Introduction
12.2.4 Pfizer Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 Duodenal Ulcer Treatment Introduction
12.3.4 Abbott Laboratories Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.3.5 Abbott Laboratories Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Duodenal Ulcer Treatment Introduction
12.4.4 Merck Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Nihon Pharmaceuticals
12.5.1 Nihon Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Duodenal Ulcer Treatment Introduction
12.5.4 Nihon Pharmaceuticals Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.5.5 Nihon Pharmaceuticals Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Duodenal Ulcer Treatment Introduction
12.6.4 Novartis Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Bristol Meyer Squibb
12.7.1 Bristol Meyer Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 Duodenal Ulcer Treatment Introduction
12.7.4 Bristol Meyer Squibb Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.7.5 Bristol Meyer Squibb Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Duodenal Ulcer Treatment Introduction
12.8.4 AstraZeneca Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Takeda
12.9.1 Takeda Company Details
12.9.2 Company Description and Business Overview
12.9.3 Duodenal Ulcer Treatment Introduction
12.9.4 Takeda Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.9.5 Takeda Recent Development
12.10 Ei Sai
12.10.1 Ei Sai Company Details
12.10.2 Company Description and Business Overview
12.10.3 Duodenal Ulcer Treatment Introduction
12.10.4 Ei Sai Revenue in Duodenal Ulcer Treatment Business (2014-2019)
12.10.5 Ei Sai Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

Checkout Inquiry Sample